5-132395612-A-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_ModerateBP6_ModerateBA1

The NM_003060.4(SLC22A5):​c.*1340A>T variant causes a splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.752 in 152,778 control chromosomes in the GnomAD database, including 45,005 homozygotes. In-silico tool predicts a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.75 ( 44807 hom., cov: 33)
Exomes 𝑓: 0.83 ( 198 hom. )

Consequence

SLC22A5
NM_003060.4 splice_region

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 3.34

Publications

26 publications found
Variant links:
Genes affected
SLC22A5 (HGNC:10969): (solute carrier family 22 member 5) Polyspecific organic cation transporters in the liver, kidney, intestine, and other organs are critical for elimination of many endogenous small organic cations as well as a wide array of drugs and environmental toxins. The encoded protein is a plasma integral membrane protein which functions both as an organic cation transporter and as a sodium-dependent high affinity carnitine transporter. The encoded protein is involved in the active cellular uptake of carnitine. Mutations in this gene are the cause of systemic primary carnitine deficiency (CDSP), an autosomal recessive disorder manifested early in life by hypoketotic hypoglycemia and acute metabolic decompensation, and later in life by skeletal myopathy or cardiomyopathy. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Apr 2015]
SLC22A5 Gene-Disease associations (from GenCC):
  • systemic primary carnitine deficiency disease
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, ClinGen, G2P, Orphanet, PanelApp Australia, Labcorp Genetics (formerly Invitae), Myriad Women’s Health
  • short QT syndrome
    Inheritance: AR Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.3).
BP6
Variant 5-132395612-A-T is Benign according to our data. Variant chr5-132395612-A-T is described in ClinVar as Benign. ClinVar VariationId is 907610.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.889 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC22A5NM_003060.4 linkc.*1340A>T splice_region_variant Exon 10 of 10 ENST00000245407.8 NP_003051.1
SLC22A5NM_003060.4 linkc.*1340A>T 3_prime_UTR_variant Exon 10 of 10 ENST00000245407.8 NP_003051.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC22A5ENST00000245407.8 linkc.*1340A>T splice_region_variant Exon 10 of 10 1 NM_003060.4 ENSP00000245407.3
SLC22A5ENST00000245407.8 linkc.*1340A>T 3_prime_UTR_variant Exon 10 of 10 1 NM_003060.4 ENSP00000245407.3

Frequencies

GnomAD3 genomes
AF:
0.752
AC:
114408
AN:
152092
Hom.:
44809
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.508
Gnomad AMI
AF:
0.861
Gnomad AMR
AF:
0.810
Gnomad ASJ
AF:
0.869
Gnomad EAS
AF:
0.911
Gnomad SAS
AF:
0.831
Gnomad FIN
AF:
0.870
Gnomad MID
AF:
0.712
Gnomad NFE
AF:
0.843
Gnomad OTH
AF:
0.789
GnomAD4 exome
AF:
0.835
AC:
474
AN:
568
Hom.:
198
Cov.:
0
AF XY:
0.841
AC XY:
281
AN XY:
334
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AF:
0.775
AC:
107
AN:
138
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
0.856
AC:
363
AN:
424
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
1.00
AC:
2
AN:
2
Other (OTH)
AF:
0.500
AC:
2
AN:
4
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
3
7
10
14
17
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.752
AC:
114435
AN:
152210
Hom.:
44807
Cov.:
33
AF XY:
0.756
AC XY:
56252
AN XY:
74430
show subpopulations
African (AFR)
AF:
0.508
AC:
21071
AN:
41492
American (AMR)
AF:
0.810
AC:
12393
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.869
AC:
3017
AN:
3472
East Asian (EAS)
AF:
0.911
AC:
4721
AN:
5184
South Asian (SAS)
AF:
0.831
AC:
4011
AN:
4828
European-Finnish (FIN)
AF:
0.870
AC:
9212
AN:
10594
Middle Eastern (MID)
AF:
0.704
AC:
207
AN:
294
European-Non Finnish (NFE)
AF:
0.843
AC:
57363
AN:
68020
Other (OTH)
AF:
0.783
AC:
1655
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1295
2591
3886
5182
6477
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
848
1696
2544
3392
4240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.787
Hom.:
6072
Bravo
AF:
0.738
Asia WGS
AF:
0.803
AC:
2788
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Renal carnitine transport defect Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.30
CADD
Benign
17
DANN
Benign
0.85
PhyloP100
3.3
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs274547; hg19: chr5-131731304; API